Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Safronac SP 100 mg/325 mg/10 mg Tablet is used for pain relief. It relieves pain in conditions like headache, mild migraine, musculoskeletal pain or painful menses.
1 Strip of 10 Tablet
Saffron Therapeutics Pvt Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Safronac SP 100 mg/325 mg/10 mg Tablet is to be taken with food.
Safronac SP 100 mg/325 mg/10 mg Tablet is a combination of three medicines: Aceclofenac, Paracetamol/Acetaminophen and Serratiopeptidase. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID), and Paracetamol/Acetaminophen is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation and promotes healing.
Related Warnings
Taking Aceclofenac+Paracetamol/Acetaminophen+Serratiopeptidase with alcohol can cause liver damage.
Safronac SP 100 mg/325 mg/10 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Safronac SP 100 mg/325 mg/10 mg Tablet during lactation. Please consult your doctor.
Safronac SP 100 mg/325 mg/10 mg Tablet may make you feel dizzy, drowsy or affect your vision. Do not drive until your vision is clear.
Safronac SP 100 mg/325 mg/10 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Safronac SP 100 mg/325 mg/10 mg Tablet may be needed. Please consult your doctor.
Use of Safronac SP 100 mg/325 mg/10 mg Tablet is not recommended in patients with severe kidney disease.
Safronac SP 100 mg/325 mg/10 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Safronac SP 100 mg/325 mg/10 mg Tablet may be needed. Please consult your doctor.
However, the use of Safronac SP 100 mg/325 mg/10 mg Tablet is not recommended in patients with severe liver disease and active liver disease.
